Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98298439 | 9829843 | 9 | F | 201202 | 20160921 | 20140120 | 20160928 | EXP | CA-ROCHE-1334582 | ROCHE | 51.67 | YR | M | Y | 90.00000 | KG | 20160928 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98298439 | 9829843 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | 225 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 98298439 | 9829843 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Unknown | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 10 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 11 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 12 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 13 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 14 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 15 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 98298439 | 9829843 | 16 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | 225 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 98298439 | 9829843 | 17 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 0 | |||||||||||
| 98298439 | 9829843 | 18 | C | ALVESCO | CICLESONIDE | 1 | Unknown | 0 | |||||||||||
| 98298439 | 9829843 | 19 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | 0 | |||||||||||
| 98298439 | 9829843 | 20 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 50 | MG | |||||||||
| 98298439 | 9829843 | 21 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98298439 | 9829843 | 1 | Asthma |
| 98298439 | 9829843 | 17 | Product used for unknown indication |
| 98298439 | 9829843 | 18 | Product used for unknown indication |
| 98298439 | 9829843 | 19 | Product used for unknown indication |
| 98298439 | 9829843 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98298439 | 9829843 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98298439 | 9829843 | Arthralgia | |
| 98298439 | 9829843 | Arthritis | |
| 98298439 | 9829843 | Blood pressure diastolic decreased | |
| 98298439 | 9829843 | Blood pressure increased | |
| 98298439 | 9829843 | Cough | |
| 98298439 | 9829843 | Dizziness | |
| 98298439 | 9829843 | Dyspnoea | |
| 98298439 | 9829843 | Fatigue | |
| 98298439 | 9829843 | Hunger | |
| 98298439 | 9829843 | Lower respiratory tract congestion | |
| 98298439 | 9829843 | Malaise | |
| 98298439 | 9829843 | Muscle spasms | |
| 98298439 | 9829843 | Nasopharyngitis | |
| 98298439 | 9829843 | Nausea | |
| 98298439 | 9829843 | Productive cough | |
| 98298439 | 9829843 | Upper respiratory tract infection | |
| 98298439 | 9829843 | Urticaria | |
| 98298439 | 9829843 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98298439 | 9829843 | 1 | 20100218 | 0 | ||
| 98298439 | 9829843 | 2 | 20130326 | 0 | ||
| 98298439 | 9829843 | 3 | 20130904 | 0 | ||
| 98298439 | 9829843 | 4 | 201309 | 0 | ||
| 98298439 | 9829843 | 5 | 20131015 | 0 | ||
| 98298439 | 9829843 | 6 | 20131128 | 0 | ||
| 98298439 | 9829843 | 7 | 20131210 | 0 | ||
| 98298439 | 9829843 | 8 | 20140107 | 0 | ||
| 98298439 | 9829843 | 9 | 20140123 | 0 | ||
| 98298439 | 9829843 | 10 | 20140207 | 0 | ||
| 98298439 | 9829843 | 11 | 20140220 | 0 | ||
| 98298439 | 9829843 | 12 | 20140416 | 0 | ||
| 98298439 | 9829843 | 13 | 20140429 | 0 | ||
| 98298439 | 9829843 | 14 | 20150211 | 0 | ||
| 98298439 | 9829843 | 15 | 20150311 | 0 | ||
| 98298439 | 9829843 | 20 | 20110610 | 0 | ||
| 98298439 | 9829843 | 21 | 201302 | 0 |